Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | MGAM | O43451 | 1/20 | 0.50 |
| ▸ | SI | P14410 | 1/20 | 0.50 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.41 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16046274 | 0.90 | FAAH (0.53) | GAAMGAMSIMGAM2CYP1A2 | |
| Succinic Acid Diethyl Ester SCHEMBL11514685 | 0.87 | GAA (0.57) | GAAMGAMSIMGAM2CYP1A2 | |
| SCHEMBL25767065 | 0.87 | FAAH (0.42) | GAAMGAMSIMGAM2CYP1A2 | |
| SCHEMBL3007115 | 0.86 | TSHR (0.56) | GAAMGAMSIMGAM2FAAH | |
| SCHEMBL11484524 | 0.86 | FAAH (0.58) | GAAMGAMSIMGAM2CYP1A2 | |
| SCHEMBL15842189 | 0.86 | CYP1A2 (0.57) | GAAMGAMSIMGAM2CYP1A2 | |
| Succinic Acid Diethyl Ester SCHEMBL22780 | 0.84 | GAA (0.67) | GAAMGAMSIMGAM2CYP1A2 | |
| Succinic Acid Diethyl Ester SCHEMBL27768067 | 0.84 | GAA (0.67) | GAAMGAMSIMGAM2CYP1A2 | |
| Succinic Acid Diethyl Ester SCHEMBL4324913 | 0.82 | GAA (0.63) | GAAMGAMSIMGAM2CYP1A2 | |
| Succinic Acid Diethyl Ester SCHEMBL21815758 | 0.82 | GAA (0.63) | GAAMGAMSIMGAM2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113038928-B | Preventing oxidation of flavor raw material and food raw material | 弗门尼舍有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-115996696-A | Prevention, reduction or improvement of odor of elderly people | 弗门尼舍有限公司 | 2023-04-21 | — | — | CN | claimed |
| EP-4164587-A1 | PREVENTION, REDUCTION, OR AMELIORATION OF OLD PERSON SMELL | Firmenich SA (CH) | 2023-04-19 | — | — | EP | claimed |
| CN-113038928-A | Preventing oxidation of flavor and food materials | 弗门尼舍有限公司 | 2021-06-25 | — | — | CN | claimed |
| US-10807979-B2 | 4,5-disubstituted-1H-pyrrolo(2,3-f)quinolin-2,7,9-tricarboxylate compound and use thereof | SHANGDONG CAMASY BIOTECHNOLOGY CO., LTD. (CN) | 2020-10-20 | — | — | US | claimed |
| EP-3643714-A1 | 4,5-DISUBSTITUTED-1-HYDRO-PYRROLE(2,3-F)QUINOLONE-2,7,9-TRICARBOXYLATE COMPOUND AND APPLICATIONS | Wang, Jinglin (CN) | 2020-04-29 | — | — | EP | claimed |
| US-20200071319-A1 | 4,5-DISUBSTITUTED-1H-PYRROLO(2,3-F)QUINOLIN-2,7,9-TRICARBOXYLATE COMPOUND AND USE THEREOF | WANG, Jinglin (CN) | 2020-03-05 | — | — | US | claimed |
| EP-2555803-B1 | PROCESS FOR PREPARING HYPERPOLARIZED SUBSTRATES AND METHOD FOR MRI | BRACCO IMAGING SPA (IT) | 2018-09-12 | — | — | EP | claimed |
| CN-102892434-B | Method for preparing hyperpolarized substrates and MRI method | BRACCO IMAGING SPA | 2014-11-19 | — | — | CN | claimed |
| CN-102892434-A | Method for preparing hyperpolarized substrates and MRI method | BRACCO IMAGING SPA | 2013-01-23 | — | — | CN | claimed |
| US-20030181506-A1 | Selective preventives/remedies for progressive lesions after organ damage | ISHIBASHI, MICHIO (JP) | 2003-09-25 | — | — | US | claimed |
| EP-1277747-A1 | SELECTIVE PREVENTIVES/REMEDIES FOR PROGRESSIVE LESIONS AFTER ORGAN DAMAGE | Ishibashi, Michio (JP) | 2003-01-22 | — | — | EP | claimed |
| EP-4682151-A2 | PRODRUGS OF ALPHA-KETOGLUTARATE, ALPHA-KETOBUTYRATE, ALPHA-KETOISOVALERATE, AND ALPHA-KETOISOHEXANOATE, AND USES THEREOF | The Regents of The University of California (US) | 2026-01-21 | — | — | EP | disclosed |
| EP-3867223-B1 | PRODRUGS OF ALPHA-KETOGLUTARATE, ALPHA-KETOBUTYRATE, ALPHA-KETOISOVALERATE, AND ALPHA-KETOISOHEXANOATE, AND USES THEREOF | UNIV CALIFORNIA (US) | 2025-12-10 | — | — | EP | disclosed |
| US-12435294-B2 | Prevention of the oxidation of perfumery raw materials and food raw materials | FIRMENICH SA (CH) | 2025-10-07 | — | — | US | disclosed |
| US-20250051321-A1 | TRICYCLIC DERIVATIVE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | SHANGHAI JEMINCARE PHARMACEUTICAL CO., LTD. (CN) | 2025-02-13 | — | — | US | disclosed |
| US-4324730-A | Certain fluorine substituted PGI2 compounds | THE UNIVERSITY OF CHICAGO (US) | 1982-04-13 | — | — | US | disclosed |
| EP-0037422-A4 | FLUORO-SUBSTITUTED PROSTAGLANDINS AND PROSTACYCLINS. | UNIV CHICAGO (US) | 1982-01-26 | — | — | EP | disclosed |
| EP-0037422-A1 | FLUORO-SUBSTITUTED PROSTAGLANDINS AND PROSTACYCLINS | UNIVERSITY OF CHICAGO (US) | 1981-10-14 | — | — | EP | disclosed |
| WO-1981001002-A1 | FLUORO-SUBSTITUTED PROSTAGLANDINS AND PROSTACYCLINS | UNIV CHICAGO (US) | 1981-04-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250051321-A1 | TRICYCLIC DERIVATIVE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | HABP2, NOTUM, SENP8 | GAA 866/4885MGAM 1506/4885SI 84/4885 |
| US-20030181506-A1 | Selective preventives/remedies for progressive lesions after organ damage | CCL11, CD68, CCL2 | GAA 868/4885MGAM 1670/4885SI 920/4885 |
| US-10807979-B2 | 4,5-disubstituted-1H-pyrrolo(2,3-f)quinolin-2,7,9-tricarboxylate compound and use thereof | MT-ND4L, GLUL, SDHA | GAA 2087/4885MGAM 3311/4885SI 3519/4885 |
| US-12435294-B2 | Prevention of the oxidation of perfumery raw materials and food raw materials | CUTA, MPO, GPX4 | GAA 1819/4885MGAM 1314/4885SI 492/4885 |
| US-20200071319-A1 | 4,5-DISUBSTITUTED-1H-PYRROLO(2,3-F)QUINOLIN-2,7,9-TRICARBOXYLATE COMPOUND AND USE THEREOF | MT-ND4L, GLUL, SDHA | GAA 2087/4885MGAM 3311/4885SI 3519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.